ArticleQuantitative imaging in medicine and surgery2025
Development and validation of an MRI radiomics-based interpretable machine learning model for predicting the progression-free survival in locally advanced nasopharyngeal carcinoma.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and validation of a machine learning model for predicting 3-year overall survival in metastatic nasopharyngeal carcinoma: a SEER database and web visualization study.Translational cancer research · 2025Article
- Dual-energy CT-based nomogram for predicting progression-free survival in locally advanced nasopharyngeal carcinoma.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Locally advanced nasopharyngeal carcinoma (LANPC) is a common malignant tumor of the nasopharynx, characterized by poor prognosis and a high susceptibility to recurrence and metastasis after surgery. The aim of this study was to establish and validate a radiomics model based on clinicopathological data and magnetic resonance imaging (MRI) information to predict progression-free survival (PFS) in LANPC patients, and to reveal the internal prediction process of the model through SHapley Additive exPlanation (SHAP) and image visualization techniques. Methods: A total of 1,098 patients with pathologically and clinically diagnosed LANPC were recruited from three hospitals {training, n=700 [70% from hospitals I (Guangxi Medical University Cancer Hospital) and II (Wuzhou Red Cross Hospital)]; internal validation, n=300 (remaining 30%); and external validation, n=98 [hospital III (The Second Affiliated Hospital of Guangxi Medical University)]}. Univariate Cox analysis and least absolute shrinkage and selection operator (LASSO) Cox regression were used to select radiomics features. A combined model integrating the radiomics score (radscore) and important clinicopathological factors was constructed using the eXtreme Gradient Boosting (XGBoost) algorithm. SHAP and image visualization techniques were used for interpretability analysis of prognostic models. Results: Optimal predictive performance was observed in the combined model, which integrated the radscore and important clinicopathological factors [induction chemotherapy (IC), Epstein-Barr virus (EBV)-DNA, and albumin], with Harrell concordance index (C-index) values of 0.762, 0.729, and 0.752 in the training, internal, and external validation cohorts, respectively. Ten radiomics features with the highest predictive contributions were identified using the SHAP algorithm. Two LANPC patients with similar clinicopathological stages but distinct risk levels were selected to visualize the top three radiomics features, revealing notable pixel-level visual differences in the largest layer of the tumor images. Kaplan-Meier survival analysis revealed prognostic differences between low- and high-risk groups, and the model's performance was stable across subgroups (all log-rank P<0.05). Conclusions: The interpretable model was able to accurately predict the PFS in LANPC patients. SHAP and image visualization techniques provided quantitative contribution values and image-level radiomics information, which could provide valuable additional information for individualized prognostic evaluation and clinical decision-making for patients with LANPC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.